This site is intended for healthcare professionals
News

Phase III clinical data from BE VIVID and BE READY studies of bimekizumab presented at AAD for treatment of psoriasis.- UCB.

Read time: 3 mins
Last updated:15th Jun 2020
Published:14th Jun 2020
Condition: Psoriasis
Type: drug
Register for free exclusive healthcare eLearning resources


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest